SCN4A mutation as modifying factor of Myotonic Dystrophy Type 2 phenotype

E. Bugiardini, I. Rivolta, A. Binda, A. Soriano Caminero, F. Cirillo, A. Cinti, R. Giovannoni, A. Botta, R. Cardani, M. P. Wicklund, G. Meola

Research output: Contribution to journalArticlepeer-review

Abstract

In myotonic dystrophy type 2 (DM2), an association has been reported between early and severe myotonia and recessive chloride channel (. CLCN1) mutations. No DM2 cases have been described with sodium channel gene (. SCN4A) mutations. The aim is to describe a DM2 patient with severe and early onset myotonia and co-occurrence of a novel missense mutation in SNC4A. A 26-year-old patient complaining of hand cramps and difficulty relaxing her hands after activity was evaluated at our department. Neurophysiology and genetic analysis for DM1, DM2, CLCN1 and SCN4A mutations were performed. Genetic testing was positive for DM2 (2650 CCTG repeat) and for a variant c.215C>T (p.Pro72Leu) in the SCN4A gene. The variation affects the cytoplasmic N terminus domain of Nav1.4, where mutations have never been reported. The biophysical properties of the mutant Nav1.4 channels were evaluated by whole-cell voltage-clamp analysis of heterologously expressed mutant channel in tsA201 cells. Electrophysiological studies of the P72L variant showed a hyperpolarizing shift (-5mV) of the voltage dependence of activation that may increase cell excitability. This case suggests that SCN4A mutations may enhance the myotonic phenotype of DM2 patients and should be screened for atypical cases with severe myotonia.

Original languageEnglish
Pages (from-to)301-307
Number of pages7
JournalNeuromuscular Disorders
Volume25
Issue number4
DOIs
Publication statusPublished - Apr 1 2015

Keywords

  • Myotonia
  • Myotonic dystrophy type 2
  • N-terminus
  • SCN4A

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Genetics(clinical)
  • Neurology
  • Medicine(all)

Fingerprint Dive into the research topics of 'SCN4A mutation as modifying factor of Myotonic Dystrophy Type 2 phenotype'. Together they form a unique fingerprint.

Cite this